Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Administration, inhalation"" wg kryterium: Temat


Tytuł :
Application of inhaled drugs from the pharmacists point of view.
Autorzy :
Masaryková L
Polaščíková P
Pokaż więcej
Transliterated Title :
Aplikácia inhalačných liekov z pohľadu lekárnika.
Źródło :
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti [Ceska Slov Farm] 2020 Fall; Vol. 69 (4), pp. 172-184.
Typ publikacji :
Journal Article
MeSH Terms :
Administration, Inhalation*
Pharmaceutical Preparations*
Pharmacists*
Dry Powder Inhalers ; Humans ; Metered Dose Inhalers
Czasopismo naukowe
Tytuł :
Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group.
Autorzy :
Mitchell JP; Jolyon Mitchell Inhaler Consultancy Services, Inc., London, Ontario, Canada.
Berlinski A; Pulmonology Division, Department of Pediatrics, University of Arkansas for Medical Sciences, College of Medicine, Little Rock, Arkansas, USA.
Canisius S; ACLiRA Consulting GmbH, Ebsdorfergrund, Germany.
Cipolla D; Insmed, Inc., Bridgewater, New Jersey, USA.
Dolovich MB; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Gonda I; Respidex LLC, Dennis, Massachusetts, USA.
Hochhaus G; College of Pharmacy, University of Florida, Gainesville, Florida, USA.
Kadrichu N; Inspired-Pulmonary Solutions LLC, San Carlos, California, USA.
Lyapustina S; Faegre Drinker Biddle & Reath LLP, Washington, District of Columbia, USA.
Mansour HM; College of Pharmacy, College of Medicine and The University of Arizona-Tucson, Tucson, Arizona, USA.
Darquenne C; Department of Medicine, UCSD, La Jolla, California, USA.
Clark AR; Aerogen Pharma Corporation, San Mateo, California, USA.
Newhouse M; St. Joseph's Hospital Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.; Firestone Institute for Respiratory Health, McMaster University, Hamilton, Ontario, Canada.
Ehrmann S; Centre Hospitalier Régional et Universitaire de Tours, Médecine Intensive Réanimation, Tours, France.
Humphries R; VisionRealisation, Shepshed, Leicestershire, United Kingdom.
Boushey H; School of Medicine, Universtiy of California San Francisco, San Francisco, California, USA.
Pokaż więcej
Źródło :
Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2020 Aug; Vol. 33 (4), pp. 235-238. Date of Electronic Publication: 2020 Jun 23.
Typ publikacji :
Letter
MeSH Terms :
Administration, Inhalation*
Coronavirus Infections/*drug therapy
Pneumonia, Viral/*drug therapy
Aerosols ; Betacoronavirus ; COVID-19 ; Decision Making ; Humans ; Pandemics ; SARS-CoV-2 ; Societies, Medical
Opinia redakcyjna
Tytuł :
Numerical evaluation of spray position for improved nasal drug delivery.
Autorzy :
Basu S; Department of Mechanical Engineering, South Dakota State University, Brookings, SD, 57007, United States. .
Holbrook LT; Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC, 27599, United States.
Kudlaty K; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Fasanmade O; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Wu J; Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC, 27599, United States.
Burke A; Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC, 27599, United States.
Langworthy BW; Department of Biostatistics, University of North Carolina, Chapel Hill, NC, 27599, United States.
Farzal Z; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Mamdani M; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Bennett WD; Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC, 27599, United States.
Fine JP; Department of Biostatistics, University of North Carolina, Chapel Hill, NC, 27599, United States.
Senior BA; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Zanation AM; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Ebert CS Jr; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Kimple AJ; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Thorp BD; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Frank-Ito DO; Department of Head and Neck Surgery & Communication Sciences, Duke University Medical Center, Durham, NC, 27708, United States.
Garcia GJM; Joint Department of Biomedical Engineering, Medical College of Wisconsin and Marquette University, Milwaukee, WI, 53226, United States.
Kimbell JS; Department of Otolaryngology/Head and Neck Surgery, School of Medicine - University of North Carolina, Chapel Hill, NC, 27599, United States.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Jun 29; Vol. 10 (1), pp. 10568. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Administration, Inhalation*
Betacoronavirus*
Nasal Sprays*
Administration, Intranasal/*methods
Coronavirus Infections/*prevention & control
Drug Delivery Systems/*methods
Pandemics/*prevention & control
Pneumonia, Viral/*prevention & control
COVID-19 ; Computer Simulation ; Coronavirus Infections/virology ; Humans ; Hydrodynamics ; Nasal Cavity/anatomy & histology ; Nasal Mucosa/drug effects ; Nasal Mucosa/virology ; Nebulizers and Vaporizers ; Paranasal Sinuses/drug effects ; Paranasal Sinuses/virology ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Viral Vaccines/administration & dosage
Czasopismo naukowe
Tytuł :
Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection.
Autorzy :
Ameratunga R; Department of Clinical Immunology, Auckland Hospital, Auckland; Department of Virology and Immunology, Auckland Hospital, Auckland; Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland.
Lehnert K; School of Biological Sciences, University of Auckland, Auckland.
Leung E; Auckland Cancer Society Research Centre, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland.
Comoletti D; School of Biological Sciences, Victoria University of Wellington, Kelburn Parade, Wellington.
Snell R; School of Biological Sciences, University of Auckland, Auckland.
Woon ST; Department of Virology and Immunology, Auckland Hospital, Auckland.
Abbott W; Department of Surgery, Auckland Hospital, Auckland.
Mears E; School of Biological Sciences, University of Auckland, Auckland.
Steele R; Department of Virology and Immunology, Auckland Hospital, Auckland; Department of Respiratory Medicine, Wellington Hospital, Wellington.
McKee J; Ecosure-Avisure Group, Burleigh Heads, Queensland, Australia.
Muscroft-Taylor A; Callaghan Innovations, Protein Science and Engineering, Christchurch.
Ameratunga S; Population Health Directorate, Counties Manukau District Health Board, Auckland.
Medlicott N; School of Pharmacy, University of Otago, Dunedin.
Das S; School of Pharmacy, University of Otago, Dunedin.
Rolleston W; South Pacific Sera, Timaru.
Quiñones-Mateu M; Department of Microbiology and Immunology, University of Otago, Dunedin.
Petousis-Harris H; Faculty of Medical and Health Sciences, University of Auckland, Auckland.
Jordan A; Department of Clinical Immunology, Auckland Hospital, Auckland.
Pokaż więcej
Źródło :
The New Zealand medical journal [N Z Med J] 2020 May 22; Vol. 133 (1515), pp. 112-118. Date of Electronic Publication: 2020 May 22.
Typ publikacji :
Journal Article
MeSH Terms :
Administration, Inhalation*
Coronavirus Infections/*drug therapy
Peptidyl-Dipeptidase A/*therapeutic use
Pneumonia, Viral/*drug therapy
Angiotensin-Converting Enzyme 2 ; Betacoronavirus ; COVID-19 ; Humans ; Lung/virology ; Pandemics ; Peptidyl-Dipeptidase A/administration & dosage ; Protein Binding ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/therapeutic use ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Particle engineered mannitol for carrier-based inhalation - A serious alternative?
Autorzy :
Hertel N; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Grasweg 9a, 24118 Kiel, Germany.
Birk G; Merck KGaA, Frankfurter Straße 250, 64293 Darmstadt, Germany.
Scherließ R; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Grasweg 9a, 24118 Kiel, Germany. Electronic address: .
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2020 Mar 15; Vol. 577, pp. 118901. Date of Electronic Publication: 2019 Dec 15.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Administration, Inhalation*
Drug Carriers*
Mechanical Phenomena*
Budesonide/*administration & dosage
Dry Powder Inhalers/*statistics & numerical data
Lactose/*administration & dosage
Mannitol/*administration & dosage
Albuterol/administration & dosage ; Particle Size
Czasopismo naukowe
Tytuł :
Pharmacokinetics, pharmacodynamics and safety of a novel extrafine BDP/FF/GB combination delivered via metered-dose inhaler in healthy Chinese subjects.
Autorzy :
Hu C; GCP Center / Institute of Drug Clinical Trials, West China Hospital, Sichuan University, Chengdu 610041, PR China.
Miao J; GCP Center / Institute of Drug Clinical Trials, West China Hospital, Sichuan University, Chengdu 610041, PR China.
Shu S; GCP Center / Institute of Drug Clinical Trials, West China Hospital, Sichuan University, Chengdu 610041, PR China.
Wang Y; GCP Center / Institute of Drug Clinical Trials, West China Hospital, Sichuan University, Chengdu 610041, PR China.
Zhu X; GCP Center / Institute of Drug Clinical Trials, West China Hospital, Sichuan University, Chengdu 610041, PR China.
Luo Z; GCP Center / Institute of Drug Clinical Trials, West China Hospital, Sichuan University, Chengdu 610041, PR China. Electronic address: .
Pokaż więcej
Źródło :
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2020 Mar 01; Vol. 144, pp. 105198. Date of Electronic Publication: 2019 Dec 17.
Typ publikacji :
Journal Article
MeSH Terms :
Administration, Inhalation*
Metered Dose Inhalers*
Beclomethasone/*pharmacology
Formoterol Fumarate/*pharmacology
Glycopyrrolate/*pharmacology
Adult ; Beclomethasone/administration & dosage ; Beclomethasone/blood ; Beclomethasone/pharmacokinetics ; Drug Combinations ; Female ; Formoterol Fumarate/administration & dosage ; Formoterol Fumarate/blood ; Formoterol Fumarate/pharmacokinetics ; Glycopyrrolate/administration & dosage ; Glycopyrrolate/blood ; Glycopyrrolate/pharmacokinetics ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial.
Autorzy :
Niederman MS; Division of Pulmonary and Critical Care Medicine, New York Presbyterian/Weill Cornell Medical Center, New York, NY, USA. Electronic address: .
Alder J; Anti-Infective Consulting, Margaretville, NY, USA.
Bassetti M; Infectious Diseases Clinic, Department of Health Sciences, University of Genoa and Policlinico San Martino Hospital, Genoa, Italy; Department of Health Sciences, University of Genoa, Genoa, Italy.
Boateng F; Bayer Healthcare Inc, Whippany, NJ, USA.
Cao B; Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China.
Corkery K; Novartis Pharmaceuticals, San Carlos, CA, USA.
Dhand R; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, USA.
Kaye KS; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Lawatscheck R; Bayer AG, Berlin, Germany.
McLeroth P; Covance, Princeton, NJ, USA.
Nicolau DP; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.
Wang C; Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China.
Wood GC; Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, University of Tennessee, Memphis, TN, USA.
Wunderink RG; Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Chastre J; Intensive Care Unit, Sorbonne University Hospitals, Paris, France.
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Mar; Vol. 20 (3), pp. 330-340. Date of Electronic Publication: 2019 Dec 19.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Administration, Inhalation*
Amikacin/*administration & dosage
Anti-Bacterial Agents/*administration & dosage
Gram-Negative Bacterial Infections/*drug therapy
Pneumonia, Ventilator-Associated/*drug therapy
Administration, Intravenous ; Adult ; Aged ; Anti-Bacterial Agents/adverse effects ; Double-Blind Method ; Drug Therapy, Combination/methods ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Female ; Hospitals ; Humans ; Male ; Middle Aged ; Placebos/administration & dosage ; Prospective Studies ; Standard of Care ; Survival Analysis ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
50 Years Ago in TheJournalofPediatrics: Mist Therapy: Rationale and Practice.
Autorzy :
Pinnamaneni P; Dr Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation, Chinaoutapally, Andhra Pradesh, India.
Gupta P; University College of Medical Sciences, Delhi, India.
Pokaż więcej
Źródło :
The Journal of pediatrics [J Pediatr] 2020 Feb; Vol. 217, pp. 85.
Typ publikacji :
Historical Article; Journal Article
MeSH Terms :
Administration, Inhalation*
Nebulizers and Vaporizers*
Pediatrics/*history
Respiration Disorders/*history
Aerosols ; Asthma/therapy ; Bronchodilator Agents/administration & dosage ; Child ; Cystic Fibrosis/therapy ; Epiglottitis/therapy ; History, 20th Century ; History, 21st Century ; Humans ; Laryngitis/therapy ; Patient Compliance ; Pediatrics/trends ; Propylene Glycol/administration & dosage ; Respiration Disorders/therapy ; Respiratory Tract Infections/therapy ; Sodium Chloride/administration & dosage ; Steroids/administration & dosage ; Tracheitis/therapy
Czasopismo naukowe
Tytuł :
Effectiveness of adjunctive nebulized antibiotics in critically ill patients with respiratory tract infections.
Autorzy :
Leache L; Pharmacy Services, Clínica Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain.
Aquerreta I; Pharmacy Services, Clínica Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain.
Aldaz A; Pharmacy Services, Clínica Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain.
Monedero P; Department of Anaesthesia and Intensive Care, Clínica Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain.
Idoate A; Pharmacy Services, Clínica Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain.
Ortega A; Pharmacy Services, Clínica Universidad de Navarra, Avenida Pío XII 36, 31008, Pamplona, Spain. .
Pokaż więcej
Źródło :
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2020 Feb; Vol. 39 (2), pp. 361-368. Date of Electronic Publication: 2019 Nov 16.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Administration, Inhalation*
Anti-Bacterial Agents/*administration & dosage
Respiratory Tract Infections/*drug therapy
Administration, Intravenous ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents/standards ; Calcitonin Gene-Related Peptide/blood ; Critical Illness ; Drug Administration Routes ; Female ; Humans ; Kidney/drug effects ; Kidney/physiology ; Kidney Function Tests ; Length of Stay ; Male ; Middle Aged ; Nebulizers and Vaporizers ; Respiration, Artificial ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Thermovaccination - thermoheliox as a stimulator of the immune response. Kinetics of the synthesis of antibodies and C-reactive protein in coronavirus infection.
Autorzy :
Varfolomeev SD; Institute of Physicochemical Foundations of the Functioning of Neural Network and Artificial Intelligence, Moscow State University, Leninskie Gory, 1-11B, Moscow, 119991, Russia; Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, ul. Kosygina, 4, Moscow, 119334, Russia.
Panin AA; LLC 'MedTechInnovations', Blagoveshchenskii per, 3-1, 123001, Russia.
Bykov VI; Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, ul. Kosygina, 4, Moscow, 119334, Russia.
Tsybenova SB; Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, ul. Kosygina, 4, Moscow, 119334, Russia. Electronic address: .
Zhuravel SV; N.V. Sklifosovsky Federal Research Institute of Emergency Medicine, Bol'shaya Sukharevskaya Ploshchad', 3, 129090, Russia.
Ryabokon AM; Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, ul. Kosygina, 4, Moscow, 119334, Russia; Department of Chemistry, Moscow State University, Leninskie Gory, 1-11B, Moscow, 119991, Russia.
Utkina II; N.V. Sklifosovsky Federal Research Institute of Emergency Medicine, Bol'shaya Sukharevskaya Ploshchad', 3, 129090, Russia.
Gavrilov PV; N.V. Sklifosovsky Federal Research Institute of Emergency Medicine, Bol'shaya Sukharevskaya Ploshchad', 3, 129090, Russia.
Petrikov SS; N.V. Sklifosovsky Federal Research Institute of Emergency Medicine, Bol'shaya Sukharevskaya Ploshchad', 3, 129090, Russia.
Shogenova LV; N.I. Pirogov Russian State National Research Medical University, ul. Ostrovityanova, 1, Moscow, 117997, Russia.
Chuchalin AG; N.I. Pirogov Russian State National Research Medical University, ul. Ostrovityanova, 1, Moscow, 117997, Russia.
Pokaż więcej
Źródło :
Chemico-biological interactions [Chem Biol Interact] 2021 Jan 25; Vol. 334, pp. 109339. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
COVID-19/*immunology
COVID-19/*therapy
Helium/*administration & dosage
Hyperthermia, Induced/*methods
Oxygen/*administration & dosage
Administration, Inhalation ; Adult ; Aged ; Antibodies, Viral/blood ; C-Reactive Protein/biosynthesis ; COVID-19/virology ; Hot Temperature ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Kinetics ; Middle Aged ; Models, Immunological ; SARS-CoV-2/immunology ; Vaccination/methods
Czasopismo naukowe
Tytuł :
Thermal inactivation of SARS COVID-2 virus: Are steam inhalations a potential treatment?
Autorzy :
la Marca G; Newborn Screening, Biochemistry and Pharmacology Laboratory, Meyer Children's University Hospital, Florence, Italy; Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy. Electronic address: .
Barp J; Gastroenterology and Nutrition Unit, Meyer Children's University Hospital, Florence, Italy.
Frenos S; Department of Haematology-Oncology: BMT Unit, Meyer Children's University Hospital, Florence, Italy.
Mugelli A; Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Galli L; Infectious Diseases Unit, Meyer Children's University Hospital, Florence, Italy; Department of Health Sciences, University of Florence, Italy.
Calistri E; Department of Health Sciences, University of Florence, Italy; Immunology Unit, Meyer Children's University Hospital, Florence, Italy.
Biasucci G; Pediatrics and Neonatology Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy.
De Masi S; Clinical Trial Office, Meyer Children's University Hospital, Florence, Italy.
Guerrini R; Section of Pharmacology and Toxicology, Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy; Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Meyer Children's University Hospital, Florence, Italy.
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Jan 15; Vol. 265, pp. 118801. Date of Electronic Publication: 2020 Nov 21.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hot Temperature*
SARS-CoV-2*
Steam*
COVID-19/*therapy
Administration, Inhalation ; Adult ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Polymerase Chain Reaction ; Respiratory Mucosa/virology ; Virus Shedding
Czasopismo naukowe
Tytuł :
Nitric oxide (NO) and nanoparticles - Potential small tools for the war against COVID-19 and other human coronavirus infections.
Autorzy :
Pieretti JC; Center for Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Santo André, SP, Brazil.
Rubilar O; Department of Chemical Engineering, Universidad de La Frontera, Temuco, Chile; Centro de Excelencia en Investigación Biotecnologica Aplicada al Medio Ambiente (CIBAMA-BIOREN), Universidad de La Frontera, Temuco, Chile.
Weller RB; Centre for Inflammation Research, University of Edinburgh, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK.
Tortella GR; Department of Chemical Engineering, Universidad de La Frontera, Temuco, Chile; Centro de Excelencia en Investigación Biotecnologica Aplicada al Medio Ambiente (CIBAMA-BIOREN), Universidad de La Frontera, Temuco, Chile.
Seabra AB; Center for Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Santo André, SP, Brazil. Electronic address: .
Pokaż więcej
Źródło :
Virus research [Virus Res] 2021 Jan 02; Vol. 291, pp. 198202. Date of Electronic Publication: 2020 Oct 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Antiviral Agents/*therapeutic use
COVID-19/*drug therapy
Nanoparticles/*therapeutic use
Nitric Oxide/*therapeutic use
Administration, Inhalation ; Antiviral Agents/administration & dosage ; Coronavirus Infections/drug therapy ; Drug Delivery Systems ; Humans ; Nanoparticles/administration & dosage ; Nitric Oxide/administration & dosage
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome.
Autorzy :
Longobardo A; Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK.
Montanari C; Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK.
Shulman R; Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK.
Benhalim S; Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK.
Singer M; Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK.
Arulkumaran N; Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK. Electronic address: .
Pokaż więcej
Źródło :
British journal of anaesthesia [Br J Anaesth] 2021 Jan; Vol. 126 (1), pp. e44-e46. Date of Electronic Publication: 2020 Oct 14.
Typ publikacji :
Letter; Observational Study
MeSH Terms :
Bronchodilator Agents/*administration & dosage
COVID-19/*therapy
Nitric Oxide/*administration & dosage
Respiration, Artificial/*methods
Respiratory Distress Syndrome/*therapy
Administration, Inhalation ; COVID-19/epidemiology ; Female ; Humans ; Male ; Respiratory Distress Syndrome/epidemiology ; Retrospective Studies
Raport
Tytuł :
Homemade valved holding chambers for children with airway hyperresponsiveness: A randomized crossover trial.
Autorzy :
Chaicoming K; Nursing Affairs, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Preutthipan A; Division of Pediatric Pulmonology, Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Adirekkittikun A; Division of Pediatric Pulmonology, Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Nugboon M; Nursing Affairs, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Pokaż więcej
Źródło :
Pediatric pulmonology [Pediatr Pulmonol] 2021 Jan; Vol. 56 (1), pp. 49-56. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Equipment Design*
Metered Dose Inhalers*
Albuterol/*administration & dosage
Bronchodilator Agents/*administration & dosage
Respiratory Hypersensitivity/*drug therapy
Administration, Inhalation ; Adolescent ; COVID-19 ; Child ; Cross-Over Studies ; Female ; Forced Expiratory Volume ; Humans ; Inhalation Spacers ; Male ; Pandemics ; Respiratory Hypersensitivity/physiopathology
Czasopismo naukowe
Tytuł :
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
Autorzy :
Lee LA; GlaxoSmithKline (GSK), Collegeville, PA, USA.
Bailes Z; GSK, Stockley Park West, Uxbridge, Middlesex, UK.
Barnes N; GSK, Brentford, Middlesex, UK; Barts and the London School of Medicine and Dentistry, London, UK.
Boulet LP; Laval University, Quebec, QC, Canada.
Edwards D; GSK, Stockley Park West, Uxbridge, Middlesex, UK.
Fowler A; GSK, Stockley Park West, Uxbridge, Middlesex, UK.
Hanania NA; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA.
Kerstjens HAM; University of Groningen and University Medical Center Groningen, and Groningen Research Institute for Asthma and COPD, Groningen, Netherlands.
Kerwin E; Crisor, Clinical Research Institute, Medford, OR, USA.
Nathan R; Asthma & Allergy Associates, PC and Research Center, Colorado Springs, CO, USA.
Oppenheimer J; Rutgers New Jersey Medical School, Newark, NJ, USA.
Papi A; University of Ferrara, Ferrara, Italy.
Pascoe S; GlaxoSmithKline (GSK), Collegeville, PA, USA.
Brusselle G; Ghent University Hospital, Ghent, Belgium.
Peachey G; GSK, Stockley Park West, Uxbridge, Middlesex, UK.
Sule N; GlaxoSmithKline (GSK), Collegeville, PA, USA.
Tabberer M; GSK, Stockley Park West, Uxbridge, Middlesex, UK.
Pavord ID; Nuffield Department of Medicine and Oxford Respiratory NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Jan; Vol. 9 (1), pp. 69-84. Date of Electronic Publication: 2020 Sep 09.
Typ publikacji :
Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Androstadienes/*administration & dosage
Anti-Asthmatic Agents/*administration & dosage
Asthma/*drug therapy
Benzyl Alcohols/*administration & dosage
Chlorobenzenes/*administration & dosage
Quinuclidines/*administration & dosage
Administration, Inhalation ; Androstadienes/therapeutic use ; Anti-Asthmatic Agents/therapeutic use ; Benzyl Alcohols/therapeutic use ; Chlorobenzenes/therapeutic use ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Nebulizers and Vaporizers ; Quinuclidines/therapeutic use
Czasopismo naukowe
Tytuł :
Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial.
Autorzy :
Cunningham S; Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK. Electronic address: .
Piedra PA; Department of Molecular Virology and Microbiology and Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Martinon-Torres F; Genetics, Vaccines and Pediatric Infectious Diseases Research Group, Instituto de Investigación Sanitaria de Santiago, and Translational Pediatrics and Infectious Diseases, Department of Pediatrics, Hospital Clinico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Szymanski H; Department of Paediatrics, St Hedwig of Silesia Hospital, Trzebnica, Poland.
Brackeva B; Ablynx, a Sanofi Company, Zwijnaarde, Belgium.
Dombrecht E; Ablynx, a Sanofi Company, Zwijnaarde, Belgium.
Detalle L; Ablynx, a Sanofi Company, Zwijnaarde, Belgium.
Fleurinck C; Ablynx, a Sanofi Company, Zwijnaarde, Belgium.
Pokaż więcej
Corporate Authors :
RESPIRE study group
Źródło :
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Jan; Vol. 9 (1), pp. 21-32. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Respiratory Syncytial Viruses*
Antiviral Agents/*therapeutic use
Respiratory Syncytial Virus Infections/*drug therapy
Respiratory Tract Infections/*drug therapy
Administration, Inhalation ; Antiviral Agents/administration & dosage ; Double-Blind Method ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Nebulizers and Vaporizers ; Respiratory Tract Infections/virology ; Single-Domain Antibodies/administration & dosage ; Viral Load/drug effects
Czasopismo naukowe
Tytuł :
Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities.
Autorzy :
Zhou Q; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
MacArthur MR; Department of Health Sciences & Technology, ETH Zurich, 8603 Zurich, Switzerland.
He X; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Wei X; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Zarin P; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.
Hanna BS; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.
Wang ZH; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Xiang X; Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Fish EN; Toronto General Hospital Research Institute, University Health Network and Department of Immunology, University of Toronto, Toronto, ON M5G 2M1, Canada.
Pokaż więcej
Źródło :
Viruses [Viruses] 2020 Dec 30; Vol. 13 (1). Date of Electronic Publication: 2020 Dec 30.
Typ publikacji :
Journal Article
MeSH Terms :
Antiviral Agents/*therapeutic use
COVID-19/*drug therapy
Interferon-alpha/*therapeutic use
Lung/*abnormalities
Administration, Inhalation ; Antiviral Agents/administration & dosage ; Biomarkers/blood ; C-Reactive Protein ; CD8-Positive T-Lymphocytes ; COVID-19/physiopathology ; China ; Cohort Studies ; Cytokines/immunology ; Drug Therapy, Combination ; Humans ; Indoles/administration & dosage ; Indoles/therapeutic use ; Interferon-alpha/administration & dosage ; Interleukin-10 ; Interleukin-6 ; Lung/diagnostic imaging ; Lung/pathology ; SARS-CoV-2/drug effects
Czasopismo naukowe
Tytuł :
Carbon footprint of inhalers in COPD therapy in 2018 and 2019 in Poland in response to the Kigali amendment.
Autorzy :
Płusa T; Medical Faculty Lazarski University, Warsaw, Poland.
Badowska-Kozakiewicz AM; Department of Cancer Prevention, Medical University of Warsaw, Poland.
Pokaż więcej
Źródło :
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego [Pol Merkur Lekarski] 2020 Dec 22; Vol. 48 (288), pp. 391-393.
Typ publikacji :
Journal Article
MeSH Terms :
Carbon Footprint*
Pulmonary Disease, Chronic Obstructive*/drug therapy
Administration, Inhalation ; Bronchodilator Agents/therapeutic use ; Humans ; Metered Dose Inhalers ; Poland ; Rwanda
Czasopismo naukowe
Tytuł :
Biological effects of inhaled hydraulic fracturing sand dust. IV. Pulmonary effects.
Autorzy :
Russ KA; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.
Thompson JA; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.
Reynolds JS; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.
Mercer RR; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.
Porter DW; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.
McKinney W; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.
Dey RD; Department of Physiology and Pharmacology, Anatomy and Laboratory Medicine, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States of America; Department of Pathology, Anatomy and Laboratory Medicine, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States of America.
Barger M; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.
Cumpston J; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.
Batchelor TP; Department of Physiology and Pharmacology, Anatomy and Laboratory Medicine, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States of America; Department of Pathology, Anatomy and Laboratory Medicine, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506, United States of America.
Kashon ML; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.
Kodali V; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.
Jackson MC; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.
Sriram K; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America.
Fedan JS; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, United States of America. Electronic address: .
Pokaż więcej
Źródło :
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2020 Dec 15; Vol. 409, pp. 115284. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Inhalation Exposure/*adverse effects
Lung/*drug effects
Occupational Exposure/*adverse effects
Sand/*chemistry
Administration, Inhalation ; Animals ; Dust ; Epithelial Cells/drug effects ; Hydraulic Fracking/methods ; Male ; Methacholine Chloride/pharmacology ; Rats ; Rats, Sprague-Dawley ; Respiratory Mucosa/drug effects ; Silicon Dioxide/adverse effects ; Trachea/drug effects
Czasopismo naukowe
Tytuł :
Biological effects of inhaled hydraulic fracturing sand dust. IX. Summary and significance.
Corporate Authors :
Investigative Team; Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.
Źródło :
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2020 Dec 15; Vol. 409, pp. 115330. Date of Electronic Publication: 2020 Nov 07.
Typ publikacji :
Editorial; Research Support, N.I.H., Extramural
MeSH Terms :
Air Pollutants/*adverse effects
Inhalation Exposure/*adverse effects
Sand/*chemistry
Administration, Inhalation ; Animals ; Dust ; Hydraulic Fracking ; Male ; Occupational Exposure/adverse effects ; Rats ; Silicon Dioxide/adverse effects
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies